Page last updated: 2024-09-02

thromboxanes and Lung Diseases, Obstructive

thromboxanes has been researched along with Lung Diseases, Obstructive in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (33.33)	18.7374
1990's	2 (33.33)	18.2507
2000's	2 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cunningham, FM; Gettinby, G; Lees, P; Page, CP; Rickards, KJ	1
Bailey, SR; Cunningham, FM; Hammond, A; Marr, CM	1
Seale, JP	1
Barnes, NC	1
Alessandri, C; Basili, S; Cipollone, F; Cordova, C; Davì, G; Gazzaniga, P; Santarone, S; Vieri, M; Violi, F	1
Boddi, M; Castellani, S; Fanara, F; Gensini, GF; Neri Serneri, GG; Pezza, A; Prisco, D; Rogasi, PG; Rostagno, C	1

Reviews

2 review(s) available for thromboxanes and Lung Diseases, Obstructive

Article	Year
Prostaglandins, slow-reacting substances (leukotrienes) and the lung. Australian and New Zealand journal of medicine, 1981, Volume: 11, Issue:5 Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Asthma; Bronchi; Epoprostenol; Guinea Pigs; Humans; Indomethacin; Infant, Newborn; Lung; Lung Diseases, Obstructive; Prostaglandin-Endoperoxide Synthases; Prostaglandins; SRS-A; Thromboxanes	1981
New developments in the treatment of asthma and chronic obstructive pulmonary disease. Respiratory medicine, 1993, Volume: 87 Suppl B Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Asthma; Humans; Immunosuppression Therapy; Leukotriene Antagonists; Lung Diseases, Obstructive; Platelet Activating Factor; Thromboxanes	1993

Other Studies

4 other study(ies) available for thromboxanes and Lung Diseases, Obstructive

Article	Year
In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine blood. Journal of veterinary pharmacology and therapeutics, 2003, Volume: 26, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Administration Schedule; Horse Diseases; Horses; Infusions, Intravenous; Lipopolysaccharides; Lung Diseases, Obstructive; Phosphodiesterase Inhibitors; Rolipram; Thromboxanes	2003
Platelets in equine recurrent airway obstruction. Research in veterinary science, 2007, Volume: 82, Issue:3 Topics: Animals; Antigens; Blood Platelets; Horse Diseases; Horses; Hypersensitivity; Lung Diseases, Obstructive; Platelet Activating Factor; Platelet Aggregation; Serotonin; Thromboxanes; Time Factors	2007
Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group. American journal of respiratory and critical care medicine, 1997, Volume: 156, Issue:6 Topics: Aged; Aspirin; Blood Platelets; Creatinine; Cyclooxygenase Inhibitors; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen Inhalation Therapy; Peptide Fragments; Platelet Activation; Prothrombin; Thromboxane B2; Thromboxanes	1997
Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension. Advances in prostaglandin, thromboxane, and leukotriene research, 1985, Volume: 13 Topics: beta-Thromboglobulin; Dipyridamole; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Thromboxanes	1985